Literature DB >> 19238146

Left ventricular hypertrophy is associated with obesity, male gender, and symptoms in healthy adolescents.

Mohammad Reza Movahed1, Adolfo Martinez, Jeff Greaves, Seaneen Greaves, Holly Morrell, Mehrtash Hashemzadeh.   

Abstract

Obesity has been found to be associated with left ventricular (LV) hypertrophy (LVH). However, the occurrence of LVH in obese teenagers who are involved in sport programs has not been studied. The objective of this study was to evaluate the prevalence of LVH and its correlation with obesity, gender, and symptoms in teenage athletes. We used echocardiographic database of 1,500 adolescences between the ages of 12 and 20 years who were actively involved in school sport programs. We evaluated associations between obesity and LVH (defined as LV wall thickness (LVWT)) >12 mm, or LV mass (LVM) >215 g or relative wall thickness (RWT) >0.43) and physical symptoms. Using univariate and multivariate analysis, male gender was associated with increased LVWT (multivariate odds ratio (OR) 4.87, confidence interval (CI) 2.41-9.82). Obesity was associated with parameters of LVH using univariate and multivariate analysis. (LVM > 215 g) occurred in 10.32% of obese athletes vs. 0.2% (1/445) of controls, (OR 51.33, CI 6.05-433.8), P < 0.001, LVWT >12 mm occurred in 16.5% of obese students vs. 3.6% of controls (OR 5.2, CI 2.7-10.1, P < 0.001), RWT >0.43 occurred in 41.4% of obese students vs. 15.7% of controls (OR 3.78, CI 2.11-6.76, P < 0.001). After adjusting for age and gender, reported history of shortness of breath (SOB), fatigue and leg edema were also significantly more prevalent in obese students and in students with LVH. In conclusion obesity is associated with LVH in a population of healthy teenagers actively involved in sport programs. Furthermore, the presence of LVH was independently associated with many physical symptoms suggesting negative effect of LVH on myocardial function.

Entities:  

Mesh:

Year:  2008        PMID: 19238146     DOI: 10.1038/oby.2008.563

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  6 in total

1.  Detection of early diastolic alterations by tissue Doppler imaging in untreated childhood-onset essential hypertension.

Authors:  Ngozi C Agu; Karen McNiece Redwine; Cynthia Bell; Kathleen Marie Garcia; David S Martin; Tim S Poffenbarger; John T Bricker; Ronald J Portman; Monesha Gupta-Malhotra
Journal:  J Am Soc Hypertens       Date:  2014-02-24

2.  Factors Associated With Left Atrial Remodeling in the General Population.

Authors:  Walter Oliver; Gwendolyn Matthews; Colby R Ayers; Sonia Garg; Sachin Gupta; Ian J Neeland; Mark H Drazner; Jarett D Berry; Susan Matulevicius; James A de Lemos
Journal:  Circ Cardiovasc Imaging       Date:  2017-02       Impact factor: 7.792

3.  Relaxation and the Role of Calcium in Isolated Contracting Myocardium From Patients With Hypertensive Heart Disease and Heart Failure With Preserved Ejection Fraction.

Authors:  K Elisabeth Runte; Stephen P Bell; Donald E Selby; Tim N Häußler; Takamuru Ashikaga; Martin M LeWinter; Bradley M Palmer; Markus Meyer
Journal:  Circ Heart Fail       Date:  2017-08       Impact factor: 8.790

4.  Phylloquinone Intake Is Associated with Cardiac Structure and Function in Adolescents.

Authors:  Mary K Douthit; Mary Ellen Fain; Joshua T Nguyen; Celestine F Williams; Allison H Jasti; Bernard Gutin; Norman K Pollock
Journal:  J Nutr       Date:  2017-10-01       Impact factor: 4.798

5.  Healthy aging of the left ventricle in relationship to cardiovascular risk factors: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Chia-Ying Liu; Shenghan Lai; Nadine Kawel-Boehm; Harjit Chahal; Bharath Ambale-Venkatesh; Joao A C Lima; David A Bluemke
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

6.  Left ventricular mass is underestimated in overweight children because of incorrect body size variable chosen for normalization.

Authors:  Hubert Krysztofiak; Marcel Młyńczak; Łukasz A Małek; Andrzej Folga; Wojciech Braksator
Journal:  PLoS One       Date:  2019-05-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.